Translation Lab

Explainability, equity, usability and governance are entry requirements, not additions at the end. Phase states below describe this platform's own educational artifacts.

Six phases

From workflow gap to monitored release

No artifact advances without the named gate satisfied and a human owner recorded.

Phase 1 — Definecomplete
We build and evaluate
Workflow gap, intended users, safety risks and what the artifact must not do.
Nursing role
Nurses define what “useful” means at the bedside.
Gate: Scope and prohibition statement signed off
Phase 2 — Curatecomplete
We build and evaluate
Data quality, provenance and subgroup representation reviewed and recorded.
Nursing role
Validate that the data reflects real care processes.
Gate: Provenance and representativeness record
Phase 3 — Developactive
We build and evaluate
Interpretable methods first; guard against overfitting and leakage.
Nursing role
Assess whether outputs make clinical sense.
Gate: Interpretability review
Phase 4 — Validatepending
We build and evaluate
Test across sites and subgroups before anyone sees an output.
Nursing role
Detect inequitable impact.
Gate: Subgroup performance evidence
Phase 5 — Interfacepending
We build and evaluate
Explanations, uncertainty and locally approved pathways designed with users.
Nursing role
Test usability and relevance.
Gate: Usability and alert-relevance study
Phase 6 — Monitorpending
We build and evaluate
Track drift, safety and outcomes after release.
Nursing role
Feedback and continuous improvement.
Gate: Monitoring plan with named owner

Measure what matters

Not model accuracy alone

Earlier recognition of change62%

Synthetic cohort of simulation records

Appropriate escalation per local policy71%

Rehearsed SBAR submissions

Documented reasoning quality58%

Rubric-scored debriefs

Equity review completed before use44%

Registry records

Signal inputs opened before responding66%

Explainability interactions

Boundary

Research framing only

Everything on this page describes how an artifact would be developed and reviewed. Nothing here is a validated clinical decision-support claim, and no phase state implies regulatory clearance.

Multimodal review

Dispersed data into a reviewable clinical story

Each modality carries its own caveat. The point is a story a nurse can read and contest, not a single score.

Modality	Inputs	What it may surface	Caveat
Records & nursing narrative	Documented symptoms, fatigue, functional decline	Change in symptom burden over time	Narrative quality varies by author and shift.
Observations & labs	Temperature, heart rate, blood counts, chemistry	Pattern suggesting infection or deterioration	Timing and device source change interpretation.
Imaging & pathology	Reported imaging findings over time	Longitudinal disease tracking	Reporting intervals are irregular.
Molecular / omics	Variant and biomarker fields	Treatment-response research signatures	Research context only; not a care recommendation.
Person-reported	Nausea, distress, sleep, concerns	Surfaces what the record misses	Absent when nobody asked.